top of page

Hosted by ICCBBA, an international non-profit standards organization.


Event Information

Message from ICCBBA Organizing Chair
Dr. Ineke Slaper-Cortenbach, PhD

In 2019 the Board of Directors of ICCBBA organized an invitation only international forum on Medical Products of Human Origin (MPHO) and celebrated the organization’s 25th Anniversary.


Forum 25 was held at the SANA Lisboa Hotel in Lisbon, Portugal and brought together representatives of health organizations, regulators, and professional societies that span the entire range of MPHO to discuss common themes related to traceability, regulatory boundaries, ethics, biovigilance and healthcare technologies. The outcome of the Forum is a report that identifies practical steps that can be taken towards harmonization and forwarding the guiding principles identified by the WHO.


ICCBBA was pleased to welcome speakers, chairs, and invited delegates from more than 30 organizations and societies active in the field of MPHO to discuss important issues and challenges.


The Forum began on Wednesday, September 18, 2019 with a welcome reception and an important key note lecture by Luc Noel. In the following two days there were plenary and breakout sessions in which participants had ample opportunity to exchange their views. The Forum concluded on Friday afternoon, September 20, 2019.


We would like to thank all participants for contributing to a successful event that will help to improve the safety and quality of MPHO in the future.

Anchor 1

Attending Organizations

Africa Society for Blood Transfusion (AfSBT)
American Association of Tissue Banks (AATB)
American Society for Apheresis (ASFA)
American Society for Reproductive Medicine (ASRM)
American Society for Transplantation and Cellular Therapy (ASTCT)
America’s Blood Centers (ABC)
Arab Transfusion Medicine Forum (ATMF)
Association of Eye Banks of Asia (AEBA)
Australian Red Cross Blood Services (ARCBS)
Biotherapeutics Association of Australasia (BAA)
Brazilian Association of Hematology, Hemotherapy, and Cell Therapy (ABHH)
Chinese Society of Blood Transfusion (CSBT)
European Association of Tissue Banks (EATB)
European Blood Alliance (EBA)
European Directorate for the Quality of Medicines (EDQM)
European Eye Bank Association (EEBA)
European Society for Blood and Marrow Transplantation (EBMT)
European Society of Human Reproduction and Embryology (ESHRE)
Eye-Bank for Sight Restoration, Inc.
Eye Bank Association of America (EBAA)
Eye Bank Association of Australia and New Zealand (EBAANZ)
Foundation for the Accreditation of Cellular Therapy (FACT)
Global Alliance of Eye Bank Associations, Inc. (GAEBA)
Health Sciences Authority, Singapore (HSA)
Institute of Medical Science, University of Tokyo (IMSUT)
International Society for Cell and Gene Therapy (ISCT)
International Society of Blood Transfusion (ISBT)
Joint Accreditation Committee ISCT-Europe & EBMT (JACIE)
National Marrow Donor Program (NMDP)
Organ Preservation Alliance (OPA)
Saudi Society of Transfusion Medicine (SSTM)
The Transplantation Society (TTS)
Tissue Engineering and Regenerative Medicine International Society (TERMIS)
United States Department of Defense Armed Services Blood Program (ASBP)
World Health Organization (WHO)
World Health Organization, Regional Office for the Eastern Mediterranean (WHO - EMRO)
World Marrow Donor Association (WMDA)
World Union of Tissue Banking Associations (WUTBA)


About ISBT 128

ISBT 128 is the global standard for the terminology, identification, coding and labeling of medical products of human origin (including blood, cell, tissue, milk, and organ products). It is used in more than 87 countries across six continents and disparate health care systems. It is widely endorsed by the professional community.

The standard has been designed to ensure the highest levels of accuracy, safety, and efficiency for the benefit of donors and patients worldwide. ISBT 128 provides international consistency to support the transfer, traceability and transfusion/transplantation of blood, cells, tissues and organs.


ICCBBA is an international standards organization responsible for the management and development of the ISBT 128 Standard. For more information, please view ICCBBA's press release.

The acronym ISBT was originally derived from the important role played by the International Society of Blood Transfusion in the development of the standard. Today it expands as Information Standard for Blood and Transplant. The number 128 reflects the 128 characters of the ISO/IEC 646 7-bit character set.


The acronym ICCBBA is derived from the International Council for Commonality in Blood Banking Automation.

Anchor 1
bottom of page